The latest financial statement is for the quarter ending 2026-03-31.
| Cash Flow | 2026-03-31 |
|---|---|
| Net loss | 52,813 |
| Accounts payable and accrued liabilities | 24,429 |
| Net cash used in continuing operating activities | -28,384 |
| Proceeds from notes payable | 28,384 |
| Net cash provided by financing activities | 28,384 |
| Net decrease in cash | 0 |
LataMed AI Corp. (LMED)
LataMed AI Corp. (LMED)